NCT04133545Unknown不适用
Discontinuation for Oral Anticoagulants During the First Year of Use in Patients With Atrial Fibrillation Covered by a Medical Insurance
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 360
- 试验地点
- 1
- 主要终点
- Anticoagulant Discontinuation Rate
研究概览
简要总结
The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year
详细描述
The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year of use after their initiation during hospitalization in patients covered by our health insurance plan.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient older than 18 years of age covered by our Health Care Insurance Plan.
- •Indication for oral anticoagulation with an expected duration of use of no less than 1 year.
排除标准
- •Refusal to take part.
- •Use of oral anticoagulants within 6 months prior to admission.
- •Presence of mechanical prosthetic valve.
- •Chronic renal failure with creatinine clearance <30 mL/min (estimated using the MDRD formula).
结局指标
主要结局
Anticoagulant Discontinuation Rate
时间窗: One year
Anticoagulant Discontinuation Rate
次要结局
- Discontinuation Predictors(One year)
研究者
JOSE LUIS CARLOS NAVARRO
MD
Hospital Italiano de Buenos Aires
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve ReplacementAORTIC VALVE DISEASESThromboembolismNCT04258488Joon Bum Kim1,300
进行中（未招募）
1 期
The Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) TrialPatients with atrial fibrillation requiring anticoagulation.MedDRA version: 20.0Level: PTClassification code: 10003658Term: Atrial fibrillation Class: 100000004849CTIS2023-504504-28-00Hamilton Health Sciences Corporation6,215
已完成
不适用
Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General MedicineThromboembolismNCT03914053University Hospital, Montpellier3,387
招募中
不适用
NOACs Use in AF or VTE (SUNSHINE Registry)Oral AnticoagulantAtrial FibrillationVenous ThromboembolismNCT05378308Henan Provincial People's Hospital5,000
撤回
不适用
Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New AntidotsSevere BleedingUrgent SurgeryNCT03537521Cardioangiologisches Centrum Bethanien